Literature DB >> 18631343

High prevalence of allergic diseases and sensitization in a low allergen country.

Michael Clausen1, Sigurdur Kristjansson, Asgeir Haraldsson, Bengt Björkstén.   

Abstract

BACKGROUND: The prevalence of adult atopic diseases in Iceland is lower than in other West European countries, despite an affluent lifestyle, but limited data are available on children. The main aim of this study was to investigate the prevalence of atopic diseases and sensitivity to common allergens in 10- to 11-year-old Icelandic schoolchildren as part of phase II of the International Study of Asthma and Allergies in Children (ISAAC).
METHODS: Nine hundred and forty-six children and their parents answered a questionnaire about atopic diseases. Skin prick tests with six allergens were performed on 773 children and they were examined for signs of atopic dermatitis (AD).
RESULTS: The 12-month prevalence of allergic rhinoconjunctivitis and asthma was 11.5% and 8.9% respectively. The reported prevalence of AD was 27%, but only 9.2% had signs when inspected. A positive skin prick test (SPT) was found in 24.4% of the children, that is 18.8% to grass, 12.9% to cat, 3.6% to trees, 3.0% to Dermatophagoides pteronyssinus, 1.4% to D. farinae and 0.5% to Alternaria.
CONCLUSION: The high prevalence of atopic diseases in children at 10-11 years is surprising, as the prevalence in adults is low in Iceland. The findings resemble those in developing countries. Iceland has had an affluent lifestyle for a considerable time, but the absence of dust mites, low pet ownership and relatively low pollen counts in the country raise doubts about the role of exposure levels in the development of sensitization and atopic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18631343     DOI: 10.1111/j.1651-2227.2008.00887.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  The role of airborne proteins in atopic dermatitis.

Authors:  Sarah Grim Hostetler; Benjamin Kaffenberger; Todd Hostetler; Matthew J Zirwas
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

2.  The international school nurse asthma project: barriers related to asthma management in schools.

Authors:  Erla Kolbrun Svavarsdottir; Ann W Garwick; Lori S Anderson; Wendy S Looman; Ann Seppelt; Brynja Orlygsdottir
Journal:  J Adv Nurs       Date:  2012-08-17       Impact factor: 3.187

3.  Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study.

Authors:  Sigrídur Lára Gudmundsdóttir; Tommaso Ballarini; María L Ámundadóttir; Judit Mészáros; Jenna H Eysteinsdóttir; Ragna H Thorleifsdóttir; Sigrídur K Hrafnkelsdóttir; Heida B Bragadóttir; Saemundur Oddsson; Jonathan I Silverberg
Journal:  Dermatol Ther (Heidelb)       Date:  2022-10-14

4.  Allergy and sensitization during childhood associated with prenatal and lactational exposure to marine pollutants.

Authors:  Philippe Grandjean; Lars K Poulsen; Carsten Heilmann; Ulrike Steuerwald; Pál Weihe
Journal:  Environ Health Perspect       Date:  2010-06-01       Impact factor: 9.031

5.  House dust mites among allergic patients at the Allergy and Immunology Unit, Zagazig University: an immunologic and serologic study.

Authors:  Afaf Abd El-Raouf Taha; Samia E Etewa; Sara A Abdel-Rahman; Asmaa M Farouk Al Ghandour; Amal H Atta; Asmaa M Darwish
Journal:  J Parasit Dis       Date:  2018-06-18

6.  Interrelationships between Atopic Disorders in Children: A Meta-Analysis Based on ISAAC Questionnaires.

Authors:  David H J Pols; Jorien B Wartna; Elvira I van Alphen; Heleen Moed; Nadine Rasenberg; Patrick J E Bindels; Arthur M Bohnen
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

7.  Atopic dermatitis is a serious health problem in Poland. Epidemiology studies based on the ECAP study.

Authors:  Adam J Sybilski; Filip Raciborski; Agnieszka Lipiec; Aneta Tomaszewska; Adam Lusawa; Piotr Samel-Kowalik; Artur Walkiewicz; Edyta Krzych; Jarosław Komorowski; Bolesław Samoliński
Journal:  Postepy Dermatol Alergol       Date:  2015-02-02       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.